Voyageur Pharmaceuticals (CVE:VM) Shares Down 31.3% – What’s Next?

Shares of Voyageur Pharmaceuticals Ltd. (CVE:VMGet Free Report) fell 31.3% during trading on Thursday . The company traded as low as C$0.14 and last traded at C$0.17. 1,643,425 shares changed hands during mid-day trading, an increase of 198% from the average session volume of 550,572 shares. The stock had previously closed at C$0.24.

Voyageur Pharmaceuticals Trading Down 10.0 %

The company has a quick ratio of 0.84, a current ratio of 0.17 and a debt-to-equity ratio of 3.21. The firm’s fifty day moving average is C$0.11 and its two-hundred day moving average is C$0.08. The firm has a market cap of C$25.10 million, a P/E ratio of -18.00 and a beta of 0.32.

About Voyageur Pharmaceuticals

(Get Free Report)

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.

See Also

Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.